Development of a receptor-based 3D-QSAR study for the analysis of MMP2, MMP3, and MMP9 inhibitors
- 15 August 2008
- journal article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry
- Vol. 16 (16), 7749-7758
- https://doi.org/10.1016/j.bmc.2008.07.004
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Validating matrix metalloproteinases as drug targets and anti-targets for cancer therapyNature Reviews Cancer, 2006
- The importance of estimating the therapeutic index in the development of matrix metalloproteinase inhibitorsCardiovascular Research, 2006
- The Design, Structure, and Clinical Update of Small Molecular Weight Matrix Metalloproteinase InhibitorsCurrent Medicinal Chemistry, 2004
- The Application of X-ray, NMR, and Molecular Modeling in the Design of MMP InhibitorsCurrent Topics in Medicinal Chemistry, 2004
- MMPs inhibitors: new succinylhydroxamates with selective inhibition of MMP-2 over MMP-3Bioorganic & Medicinal Chemistry Letters, 2003
- Improved gelatinase a selectivity by novel zinc binding groups containing galardin derivativesBioorganic & Medicinal Chemistry Letters, 2003
- Matrix metalloproteinase inhibitors (MMPIs): The beginning of phase I or the termination of phase III clinical trialsCancer and Metastasis Reviews, 2003
- Matrix Metalloproteinase Inhibitors and Cancer—Trials and TribulationsScience, 2002
- Design and Therapeutic Application of Matrix Metalloproteinase InhibitorsChemical Reviews, 1999
- Matrix MetalloproteinasesJournal of Biological Chemistry, 1999